Senior insider sale
Chief Medical Officer at MAPLIGHT THERAPEUTICS, INC. — senior position signals high conviction
$1.77M
57.93K shares
What this filing means
FOFF ERIN PENNOCK plans to sell 57.93K shares of MAPLIGHT THERAPEUTICS, INC. valued at approximately $1.77M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/4/2026ACC: 0001974158-26-000065
Officer· Chief Medical Officer
Since Feb 2026
57.93K
Shares to sell
$1.77M
Approx. market value
54.72K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Vested RSU
N/A
7/5/2024
54.72KTotal acquired54.72K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/5/2024 | Vested RSU N/A | 54.72K | — |
| Total | 54.72K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
1.17K
Market value
$32.0K
4/16/2026
—Completed
Units to sell
2.04K
Market value
$54.9K
4/15/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
54.72K
Market value
$1.68M
5/4/2026
Total
Units
57.93K
Value
$1.77M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
4/16/2026 | 1.17K | $32.0K | — | Completed |
4/15/2026 | 2.04K | $54.9K | — | Completed |
| Planned — Approximate Date | ||||
5/4/2026 | 54.72K | $1.68M | NASDAQ | Planned |
| Total | 57.93K | $1.77M | ||